Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Kaveri

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Journal of Clinical Microbiology|October 16, 2001
Foot and mouth disease: a revised policy is requiredJ Bayry, S V Kaveri
The New England Journal of Medicine|September 8, 2001
Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulinM D Kazatchkine, S V Kaveri
Clinical and Experimental Immunology|November 4, 2009
Intravenous immunoglobulins. Current understanding and future directionsS Jolles, S V Kaveri, J Orange
Annales De Medecine Interne|July 18, 2000
[Immunomodulatory effects of intravenous immunoglobulins]M Kazatchkine, L Mouthon, S V Kaveri
The Journal of Clinical Investigation|August 1, 1991
Human anti-phosphorylcholine antibodies share idiotopes and are self-bindingR Halpern, S V Kaveri, H Köhler
Revue Neurologique|February 1, 1995
[Immunomodulator effects of intravenous immunoglobulins in neurological autoimmune diseases]L Mouthon, S V Kaveri, M D Kazatchkine
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locusS V Kaveri, C Y Kang, H Köhler
European Journal of Immunology|July 1, 1992
A V region-connected autoreactive subfraction of normal human serum immunoglobulin GG Dietrich, S V Kaveri, M D Kazatchkine
Seminars in Hematology|July 1, 1992
Can intravenous immunoglobulin treatment regulate autoimmune responses?S V Kaveri, G Dietrich, M D Kazatchkine
Clinical and Experimental Immunology|September 1, 1993
Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic networkN Ronda, S V Kaveri, M D Kazatchkine
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Journal of Clinical Microbiology|October 16, 2001
Foot and mouth disease: a revised policy is requiredJ Bayry, S V Kaveri
The New England Journal of Medicine|September 8, 2001
Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulinM D Kazatchkine, S V Kaveri
Clinical and Experimental Immunology|November 4, 2009
Intravenous immunoglobulins. Current understanding and future directionsS Jolles, S V Kaveri, J Orange
Annales De Medecine Interne|July 18, 2000
[Immunomodulatory effects of intravenous immunoglobulins]M Kazatchkine, L Mouthon, S V Kaveri
The Journal of Clinical Investigation|August 1, 1991
Human anti-phosphorylcholine antibodies share idiotopes and are self-bindingR Halpern, S V Kaveri, H Köhler
Revue Neurologique|February 1, 1995
[Immunomodulator effects of intravenous immunoglobulins in neurological autoimmune diseases]L Mouthon, S V Kaveri, M D Kazatchkine
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locusS V Kaveri, C Y Kang, H Köhler
European Journal of Immunology|July 1, 1992
A V region-connected autoreactive subfraction of normal human serum immunoglobulin GG Dietrich, S V Kaveri, M D Kazatchkine
Seminars in Hematology|July 1, 1992
Can intravenous immunoglobulin treatment regulate autoimmune responses?S V Kaveri, G Dietrich, M D Kazatchkine
Clinical and Experimental Immunology|September 1, 1993
Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic networkN Ronda, S V Kaveri, M D Kazatchkine
Pageof 11